INLF · INLIF Ltd
INLIF Limited, through its subsidiaries, engages in the research, development, manufacture, and sale of injection molding machine-dedicated manipulator arms under the iNLIF brand in the People's Republic of China. The company offers transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms, as well as manipulator arms accessories, including conveyor belt clamps, welded bases, and reducer mounting plates. It also provides installation and warranty services, as well as raw materials for manipulator arms. The company was founded in 2016 and is based in Quanzhou, the People's Republic of China.
Cap structure and valuation
| Cap structure | |
|---|---|
| SP | $2.71 |
| SO | 6.4M |
| Options | — |
| Warrants | — |
| FD SO | 6.4M |
| MC | $17.3M |
| Cash | $6.7M |
| Total debt | $4.6M ⚠ |
| EV | $15.2M |
| TTM Multiples | |
|---|---|
| EV / Revenue | — |
| EV / EBITDA | — |
| MC / Net Income | — |
| EV / FCF | — |
| MC / FCF | — |
| Ownership & coverage | |
|---|---|
| Institutional | 0.0% |
| Insiders | 6.5% |
| # Institutions | 7 |
| Analysts | 0 |
| Consensus | — |
| Avg target | — |
| Short % float | 3.3% |
| Days to cover | 0.00 |
MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2025-12-31. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative, or when fewer than four quarters are reported — a partial sum is not a trailing twelve months. Ownership & coverage per Yahoo Finance as of 2026-07-13 — institutional % is 13F-based, so it can lag a quarter and exceed 100% on share-count timing. Short interest per FINRA bi-monthly reporting, as of 2026-06-29; the float denominator can be unreliable on tiny floats.
This filer tags no option or warrant count, so FD SO counts it as zero and understates dilution — treat FD SO, MC and EV as a floor. (XBRL reports nothing both for a filer that has none and for one that simply doesn't tag them.)
Debt figure uncertain — overlapping debt tags exceeded total liabilities; clamped to a defensible bound (≈$9.3M dropped). Verify against the filing before relying on EV.
Financial statements
No quarterly data available.
| 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|
| Total Revenue | 18.41 | 15.80 | 12.61 | 6.65 |
| Revenue YoY % | 16.5% | 25.3% | 89.6% | — |
| Cost of Revenue | 14.11 | 11.21 | 8.45 | 4.36 |
| Gross Profit | 4.29 | 4.58 | 4.16 | 2.29 |
| Gross Profit YoY % | (6.3%) | 10.2% | 81.3% | — |
| Gross Margin % | 23.3% | 29.0% | 33.0% | 34.5% |
| SG&A | 8.04 | 1.70 | 1.41 | 1.14 |
| R&D | 2.07 | 1.56 | 1.36 | 0.50 |
| Operating Expense | 10.11 | 3.30 | 2.77 | 1.64 |
| Operating Income | (5.82) | 1.29 | 1.39 | 0.65 |
| Operating Income YoY % | (551.8%) | (7.0%) | 113.1% | — |
| Operating Margin % | (31.6%) | 8.2% | 11.0% | 9.8% |
| EBITDA | (5.53) | 1.64 | 1.75 | 1.04 |
| EBITDA Margin % | (30.0%) | 10.4% | 13.9% | 15.6% |
| Interest Expense | 0.16 | 0.20 | 0.15 | 0.08 |
| Other Income / (Expense) | 0.53 | 0.53 | — | — |
| Pretax Income | (5.45) | 1.62 | 1.36 | 0.54 |
| Tax Provision | (0.00) | 0.01 | 0.01 | (0.00) |
| Net Income | (5.45) | 1.61 | 1.35 | 0.54 |
| Net Margin % | (29.6%) | 10.2% | 10.7% | 8.1% |
| Diluted EPS | -$0.33 | $0.13 | $0.11 | $0.04 |
| Basic EPS | -$0.33 | $0.13 | $0.11 | $0.04 |
| Basic Avg Shares | 16.6 | 12.5 | 12.5 | 12.5 |
No quarterly data available.
| 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|
| Cash & Equivalents | 6.72 | 2.47 | 0.60 | 0.08 |
| Receivables | 5.91 | 3.84 | 3.79 | — |
| Inventory | 5.50 | 5.30 | 4.49 | — |
| Other Current Assets | — | 1.64 | — | — |
| Total Current Assets | 18.23 | 13.25 | 9.38 | — |
| Net PPE | 4.25 | 3.04 | 3.40 | — |
| Intangible Assets | 0.04 | 0.04 | 0.05 | — |
| Other Assets | 2.26 | 2.14 | 3.20 | — |
| Total Assets | 24.78 | 18.47 | 16.02 | — |
| Accounts Payable | 3.29 | 3.13 | 2.55 | — |
| Other Current Liabilities | 5.34 | 5.07 | 4.51 | — |
| Total Current Liabilities | 8.63 | 8.20 | 7.06 | — |
| Total Liabilities | 8.64 | 8.20 | 7.06 | — |
| Retained Earnings | (2.24) | 3.20 | 1.76 | — |
| Total Equity | 16.13 | 10.27 | 8.96 | 7.84 |
No quarterly data available.
| 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|
| Net Income | (5.45) | 1.61 | 1.35 | 0.54 |
| D&A | 0.29 | 0.35 | 0.37 | 0.39 |
| Stock-Based Comp | 5.14 | — | — | — |
| Δ Working Cap & Other | (1.88) | (0.38) | (1.32) | 0.31 |
| Operating Cash Flow | (1.89) | 1.58 | 0.40 | 1.24 |
| CapEx | (0.19) | (0.03) | (0.22) | (0.02) |
| Investing Cash Flow | (0.20) | 0.32 | (0.22) | (0.02) |
| Stock Issuance | 7.03 | — | — | — |
| Other Financing | — | — | — | (1.72) |
| Financing Cash Flow | 6.87 | 0.22 | 0.46 | (1.72) |
| Effect of FX on Cash | (0.52) | (0.26) | (0.13) | 0.40 |
| Free Cash Flow | (2.08) | 1.55 | 0.18 | 1.22 |
No quarterly data available.
| 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|
| Current Ratio | 2.11 | 1.62 | 1.33 | — |
| Quick Ratio | 1.48 | 0.97 | 0.69 | — |
| Debt / Equity | 0.54 | 0.80 | 0.79 | — |
| EBITDA Margin % | (30.0%) | 10.4% | 13.9% | 15.6% |
| Working Capital | 9.60 | 5.05 | 2.32 | — |
| Net Debt | — | — | — | — |
| ROE % | (33.8%) | 15.6% | 15.1% | 6.9% |
| ROA % | (22.0%) | 8.7% | 8.4% | — |
Insider activity (last 2 years)
| Date Filed | Reporter | Relationship | Trans. Date | Code | Shares | Price | Total Value |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | HRT FINANCIAL LP | 10% Owner | 2026-06-30 | S | (3,831,240) | $0.06 | -$218,381 |
| 2026-07-01 | HRT FINANCIAL LP | 10% Owner | 2026-06-29 | P | 2,919,237 | $0.06 | $186,831 |
| 2026-06-29 | HRT FINANCIAL LP | 10% Owner | 2026-06-26 | P | 1,689,946 | $0.06 | $94,637 |
| 2026-06-29 | HRT FINANCIAL LP | 10% Owner | 2026-06-25 | P | 1,781,958 | $0.03 | $53,459 |
| 2026-06-29 | HRT FINANCIAL LP | 10% Owner | 2026-06-24 | P | 948,910 | $0.04 | $40,803 |